World AIDS Day: Update on HIV cure research and gene therapies

by Cal Strode | Dec 1, 2025

To mark World AIDS Day, I revisited the rapidly shifting HIV cure research landscape, checking in on International AIDS Society (IAS) 2025 to see how things have evolved since 2021, when I last covered progress for Signals. Curative approaches are starting to move on...

Right Turn: Beyond the ’stache: The science, the progress, the promise

by Stacey Johnson | Nov 26, 2025

For some, it happens overnight. For others, it takes weeks of nurturing and coaxing. But most of them get there in the end. A quick glance at the calendar tells you exactly what I mean: Movember is back —the one month of the year when upper lips everywhere decide to...

The future of infertility treatments

by Ellie Kroeger | Nov 18, 2025

Globally, infertility rates are on the rise. In Canada, one in six couples – 16 per cent – experiences infertility. As a result, infertility treatments have also risen drastically in the past two decades, with almost 100,000 babies being born via in vitro...

Brain-computer interface could offer solution to people with motor neuron degeneration

by Krystal Jacques | Nov 5, 2025

Spinal cord injury, stroke and amyotrophic lateral sclerosis (ALS) are all conditions that can disrupt the critical nervous system pathways responsible for controlling muscles. This frequently leads to a profound loss of motor function, such as weakness or paralysis....

The non-dilutive funding path for biotech startups

by Laya Kiani | Oct 22, 2025

Are you an early-stage startup founder looking for funding options without giving up equity? If so, non-dilutive funding may be the solution you need. It allows startups to advance research, build credibility and move closer to commercialization while maintaining full...

Right Turn: Can Bryan Johnson live forever? Will regenerative medicine help him do so?

by Stacey Johnson | Oct 10, 2025

It’s going to be a baseball-filled Thanksgiving for Canadians this year. Go Jays go! If you are looking for something different to watch, assuming you didn’t catch it when it first aired earlier this year. I suggest you check out the Netflix documentary Don’t...

CCRM Australia: Lessons from the front line of commercialization

by CCRM Australia | Oct 1, 2025

Silvio Tiziani, MBA, GAICD, is the CEO of CCRM Australia, leading efforts to bridge the gap between research and industry in regenerative medicine. With extensive experience across academia, health, and industry, he has successfully developed strategic partnerships,...

Regenerative immunotherapy: Hope for chronic autoimmune diseases

by Guest | Sep 16, 2025

Ellie Kroeger is a writer and researcher currently studying the vaginal microbiome and vaginal microbiota transplants. She holds a B.Sc. in human biology from the University of Southern California. You can connect with her via her website...

Canada’s regenerative revolution: Why AI is the catalyst

by Guest | Sep 4, 2025

Sanat Khanna holds a Bachelor of Science in Biotechnology from India and recently completed an Advanced Diploma in Biotechnology at Centennial College. He has hands-on experience in scientific research, project coordination, and science communication, having worked in...

Summer by Design: A launchpad for future entrepreneurs and industry scientists

by Guest | Aug 14, 2025

Sylvia Almeida is a PhD candidate in the Department of Molecular Genetics at the University of Toronto. Her research leverages chemical genomics to uncover novel therapeutic strategies for human disease in collaboration with other Canadian and international academic...